Related Experiment Video
Updated: Feb 24, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
The Rac GTPase in Cancer: From Old Concepts to New Paradigms
Marcelo G Kazanietz1, Maria J Caloca2
1Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. marcelog@upenn.edu mj.caloca@csic.es.
Abstract:
Rho family GTPases are critical regulators of cellular functions that play important roles in cancer progression. Aberrant activity of Rho small G-proteins, particularly Rac1 and their regulators, is a hallmark of cancer and contributes to the tumorigenic and metastatic phenotypes of cancer cells. This review examines the multiple mechanisms leading to Rac1 hyperactivation, particularly focusing on emerging paradigms that involve gain-of-function mutations in Rac and guanine nucleotide exchange factors, defects in Rac1 degradation, and mislocalization of Rac signaling components. The unexpected pro-oncogenic functions of Rac GTPase-activating proteins also challenged the dogma that these negative Rac regulators solely act as tumor suppressors. The potential contribution of Rac hyperactivation to resistance to anticancer agents, including targeted therapies, as well as to the suppression of antitumor immune response, highlights the critical need to develop therapeutic strategies to target the Rac pathway in a clinical setting. Cancer Res; 77(20); 5445-51. ©2017 AACR.
Insights
Dysregulated Rac1 signaling drives cancer progression and metastasis. Targeting Rac1 hyperactivation offers a promising strategy for overcoming cancer treatment resistance and enhancing antitumor immunity.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Rho family GTPases, especially Rac1, are crucial for cell functions and cancer development.
- Aberrant Rac1 activity is a key feature of cancer, promoting tumor growth and metastasis.
- Understanding Rac1's role is vital for cancer research.
Purpose of the Study:
- To review mechanisms of Rac1 hyperactivation in cancer.
- To explore the dual role of Rac GTPase-activating proteins in cancer.
- To highlight Rac1's contribution to therapy resistance and immune suppression.
Main Methods:
- Literature review of Rac1 signaling in cancer.
- Analysis of genetic and regulatory mechanisms of Rac1.
- Examination of Rac1's impact on therapeutic outcomes and immunity.
Main Results:
- Rac1 hyperactivation arises from mutations, altered degradation, and mislocalization.
- GTPase-activating proteins can promote oncogenesis, challenging prior assumptions.
- Rac1 contributes to resistance against anticancer drugs and suppresses antitumor immunity.
Conclusions:
- Rac1 hyperactivation is a significant driver of cancer malignancy.
- Targeting Rac1 pathways is a necessary clinical strategy.
- Further research into Rac1 regulation and function is warranted for therapeutic development.
More Related Videos
13:51Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
08:11Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...